Navigation Links
Nonstoichiometric Compounds V - An ECI Conference Series
Date:6/27/2012

The aim of this conference is to bring together scientists from diverse disciplines, who are working on nonstoichiometric compounds (oxides, nitrides, oxynitrides, chalcogenides, intermetallics, etc.).

Traditionally, the effects of stoichiometry deviations in oxides were investigated by those looking to understand and control the electrical, diffusional, and in many cases, the mechanical properties of these materials, with the aim of using them as solid oxide fuel cell electrodes, as battery electrodes, as sensors, as permeation membranes, and in various other electrochemical reactors. Complex oxides that exhibit nonstoichiometry are now also employed for high-temperature thermoelectrics, all-oxide electronics, high speed photonics and switching, memory and magnetoresistive devices. These and other oxides are also being developed as electrodes for energy conversion and photovoltaic applications.

Furthermore, driven by the semiconductor industry interest has also expanded to include nitrides, chalcogenides, oxynitrides, oxychalcogenides, etc. Given the diverse fields of applications, it is clear that a truly international conference devoted specifically to compounds that display nonstoichiometry will allow scientists from these various fields to learn from the other fields and from other approaches, to assess the state of the art, and to discuss future developments.

Outline

This conference will cover all aspects of nonstoichiometry in inorganic compounds. Topics will span from fundamental theory to advanced characterization and device demonstrations at both the macro- and nano-scale.

The conference will last four and a half days and each half day session will consist of two keynote talks, followed by shorter presentations on current research topics germane to the keynote talks. There will also be two poster sessions.

Contributions that include one of the following aspects are welcome:

Bulk defect
'/>"/>

Contact: Kevin Korpics
kevin@engconfintl.org
Engineering Conferences International
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. New drug-screening method yields long-sought anti-HIV compounds
2. Nuisance seaweed found to produce compounds with biomedical potential
3. Heparin-like compounds inhibit breast cancer metastasis to bone
4. Sulphur and iron compounds common in old shipwrecks
5. New screening technique yields elusive compounds to block immune-regulating enzyme
6. Biosensor illuminates compounds to aid fight against TB
7. Biological and Pharmaceutical Complex Fluids Conference
8. The 1st International Conference on Neurorehabilitation to be held in Toledo, Spain
9. LEGATO conference is seeking answers through science
10. 5th Latin American Conference on Lung Cancer
11. Versatility of zebrafish research highlighted at international conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)... DUBLIN , May 26, 2015 ... has announced the addition of the "Saudi ... report to their offering. ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) ... Saudi Arabia is projected to grow ... This high growth is attributed to the surging ...
(Date:5/22/2015)... DALLAS , May 22, 2015 ... Recognition Market by Solution (2D, 3D, Thermal, Emotion, Forensic), by ... End User (Government and Utilities, Consumer and Home) - ... Market to grow from $2.77 Billion in 2015 to ... Browse 79 market data Tables and ...
(Date:5/20/2015)... DUBLIN , May 20, 2015 ... Markets ( http://www.researchandmarkets.com/research/h8t4x6/5year ) has announced the ... of the Global Iris Recognition Market" ... http://photos.prnewswire.com/prnh/20130307/600769) , ,This research service analyses ... across the government and commercial sectors, ...
Breaking Biology News(10 mins):Saudi Arabia Biometric Systems Market Forecast and Opportunities, 2020 with Morpho Safran, ZK Technlogy, and Suprema Dominating 2Facial Recognition Market Worth $6.19 Billion by 2020 2Facial Recognition Market Worth $6.19 Billion by 2020 3Global Iris Recognition Market Report 2015 - 5-Year Opportunity Analysis 2
... F.L. MARCH 27, 2009 The founder of a ... genetic tests in making medical decisions is the 2009 ... for lifetime achievement in the field of genetic sciences. ... the University of Washington School of Medicine in Seattle, ...
... Scripps Research Institute has obtained the first glimpse of a ... cells. The protein, called P-glycoprotein or P-gp for short, is ... chemotherapy drugs. Understanding its structure may help scientists design more ... March 27, 2009, issue of the journal Science . ...
... new drug developed at the University of California, Davis ... II of human clinical trials to evaluate its efficacy. ... (s-EH) inhibitor, is "a first-in-class drug which may treat ... entomologist Bruce Hammock, who with UC Berkeley cell biologist ...
Cached Biology News:Roberta A. Pagon receives lifetime award in genetics from March of Dimes 2Scripps scientists find structure of a protein that makes cancer cells resistant to chemotherapy 2Scripps scientists find structure of a protein that makes cancer cells resistant to chemotherapy 3UC Davis bench-to-bedside research: Promising treatment in clinical trials 2UC Davis bench-to-bedside research: Promising treatment in clinical trials 3UC Davis bench-to-bedside research: Promising treatment in clinical trials 4UC Davis bench-to-bedside research: Promising treatment in clinical trials 5
(Date:5/28/2015)... , May 28, 2015 Celsion Corporation (the ... has received commitments from two institutional healthcare investors to ... Company,s common stock in an at-the-market registered direct offering ... common stock. The Company entered into a ... the Company agreed to sell an aggregate of 3,000,000 ...
(Date:5/28/2015)... Dallas, TX (PRWEB) May 28, 2015 ... trade association serving and representing the life sciences ... first Board of Directors meeting at The Foundry ... meeting of the organization brought together a broad ... region, and underscored the organization's early successes in ...
(Date:5/28/2015)... Fla. , May 28, 2015 ... the anti-cancer potential of its growth hormone-releasing hormone (GHRH) ... at the 2015 ASCO Annual Meeting. The data show ... for Biscayne,s anti-cancer GHRH blockers, is present on many ... These findings suggest that GHRH antagonists could have broad ...
(Date:5/28/2015)... The Fertility Centers of New England is ... has taken on a new and expanded role as ... guidance, leadership, oversight and quality assurance for the practice. ... our team of experienced reproductive endocrinologists,” said Fertility Centers ... M.D. “Her expertise and compassionate, individualized care have helped ...
Breaking Biology Technology:Celsion Corporation Announces $8 Million At-The-Market Registered Direct Offering 2Celsion Corporation Announces $8 Million At-The-Market Registered Direct Offering 3BioNorthTX Holds Inaugural Board of Directors Meeting 2BioNorthTX Holds Inaugural Board of Directors Meeting 3Data Presented At 2015 ASCO Annual Meeting Shows Biscayne Pharmaceuticals' GHRH Antagonist Target Is Expressed Across All Breast Cancer Subtypes 2Data Presented At 2015 ASCO Annual Meeting Shows Biscayne Pharmaceuticals' GHRH Antagonist Target Is Expressed Across All Breast Cancer Subtypes 3Danielle Vitiello, MD of Fertility Centers of New England, Named New Medical Director 2
... a leader in forest tree improvement technologies, ... that are utilizing technology in-licensed from Senesco Technologies, Inc. ... companies had previously announced that trees that incorporate Senesco ... field trials. , , Selected trees from ...
... , , Data published in July 7, ... Academy of Sciences, , , QUEBEC CITY, July 7 ... TSX: AEZ), a global biopharmaceutical company focused on endocrine therapy ... journal, Proceedings of the National Academy of Sciences (PNAS), of ...
... , THE WOODLANDS, Texas, July 7 Lexicon ... biopharmaceutical company focused on discovering and developing breakthrough treatments for ... 2 clinical trial of LX1032 , the ... carcinoid syndrome . LX1032 is designed ...
Cached Biology Technology:ArborGen and Senesco Announce Wood Quality Results 2ArborGen and Senesco Announce Wood Quality Results 3ArborGen and Senesco Announce Wood Quality Results 4AEterna Zentaris: New Data Published on its Ghrelin Antagonist Compound, AEZS-123 (JMV2959), Supports its Use in Alcohol Addiction 2AEterna Zentaris: New Data Published on its Ghrelin Antagonist Compound, AEZS-123 (JMV2959), Supports its Use in Alcohol Addiction 3AEterna Zentaris: New Data Published on its Ghrelin Antagonist Compound, AEZS-123 (JMV2959), Supports its Use in Alcohol Addiction 4Lexicon Initiates Phase 2 Clinical Trial of LX1032 in Patients With Carcinoid Syndrome 2Lexicon Initiates Phase 2 Clinical Trial of LX1032 in Patients With Carcinoid Syndrome 3Lexicon Initiates Phase 2 Clinical Trial of LX1032 in Patients With Carcinoid Syndrome 4
Human GCP-2 is a member of the CXC family of chemokines. It also promotes neutrophil chemotaxis and deganulation. GF063 is an 8.0 kDa protein containing 73 amino acid residues....
... Buffer contains a precipitant to ensure that the ... dye to allow the user to follow the ... ReddyRun™: ABgene ® s proprietary mixture of ... buffer composition used in ReddyRun™ molecular weight markers. ...
... number is a new ... easily match Cornings product ... availability yet, please order ... number (Z71,381-3) or contact ...
Excellent safety and durability., Remote control can be easily operated in your hand., Constant voltage control with 2 sets of terminals., Precise and durable circuit design. ...
Biology Products: